26 May 2013
Keywords: astrazeneca, files, nexium, snda, infant, gerd, anglo-swedish
Article | 12 January 2009
Anglo-Swedish drug major AstraZeneca has submitted a supplemental New Drug Application to the US Food and Drug Administration for Nexium
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
24 May 2013
© 2013 thepharmaletter.com